Salesforce vs. International Business Machines: Which Technology Stock Is a Better Buy in 2026?

For fiscal 2025/2026, Salesforce reported revenue of about $41.5 billion, up 9.6%, and net income of $7.5 billion; IBM reported revenue of about $67.5 billion, up 7.6%, and net income of $10.6 billion. Salesforce’s latest operating margin was 21.5% versus IBM’s 21%, while IBM had the lower P/S ratio at 3.4x versus 4.7x and Salesforce the lower forward P/E at 14.9x versus 20.4x. The article frames Salesforce as the stronger growth choice and IBM as the value-oriented option, with risks including competition, AI regulation, leverage, and execution.

Analysis

The key portfolio question is whether enterprise AI expands software budgets or automates away paid seats and consulting hours. CRM has the cleaner upside if AI features raise attach rates and pricing without cannibalizing core subscriptions; otherwise agentic workflows could make seat-based CRM economics less durable. IBM can benefit from migration and implementation work, but AI-driven automation also risks reducing billable labor per project. That makes realized software growth and consulting utilization more informative than broad AI positioning.

On the supplied snapshot, CRM’s lower forward P/E despite faster growth and comparable operating margin looks more interesting than a simple growth-versus-value framing suggests. But reported cash generation needs a quality haircut for SBC, and a sub-1 current ratio merits monitoring rather than an immediate solvency conclusion. IBM’s lower sales multiple is not automatically cheap: leverage, slower growth, and foreign-exchange exposure can justify a discount. The article’s Braze acquisition reference should be independently verified; do not underwrite the thesis on it as stated.

Near term, the comparison is vulnerable to estimate revisions and valuation-data differences. Over 1–3 months, watch CRM subscription growth, AI product adoption translating into paid expansion, and IBM software growth versus consulting signings/utilization. Over 6–18 months, the decisive issue is whether AI increases customer value faster than it compresses seats or labor. A relative CRM-over-IBM position is plausible, but only after validating current estimates and prices; this article alone is not a catalyst.

Key Decisions for Investors

• Watchlist trade: consider long CRM / short IBM as a relative-value expression, sized modestly and entered only after checking live valuation, estimate revisions, and borrow/carry. The thesis is CRM growth and margin durability at a lower stated forward P/E; the main risk is CRM’s multiple rerating lower if AI fails to monetize or seat cannibalization emerges.
• For the next earnings cycle, track CRM subscription/remaining-performance-obligation growth and evidence of paid AI adoption—not product announcements alone. Falsify the long thesis if growth decelerates materially without offsetting margin or cash-flow improvement.
• Track IBM software growth, consulting bookings and utilization, plus currency effects. Falsify the short leg if software acceleration and sustained consulting demand overcome leverage and FX concerns; avoid treating its lower P/S as sufficient evidence of mispricing.
• Verify the article’s company-specific acquisition claim and the cited forward-multiple inputs before acting. If those checks or current price levels undermine the relative valuation case, there may be no trade.